On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Biomarkers in Disease Mechanisms

TopicLeading institutions, researchers & key papers

Biomarkers in Disease Mechanisms is a topic indexed in ScholarIQ from OpenAlex.

What is known about Biomarkers in Disease Mechanisms?

ScholarIQrecord summary

This cluster of papers explores the role of pentraxins, particularly PTX3, in innate immunity, inflammation, cardiovascular diseases, tissue remodeling, infection, autoimmunity, and cancer. The research covers various aspects of pentraxin function, including pattern recognition, interaction with complement system, biomarker potential, and therapeutic implications.

How many works does Biomarkers in Disease Mechanisms have?

ScholarIQindexed works

Biomarkers in Disease Mechanisms has 85 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Biomarkers in Disease Mechanisms?

ScholarIQopenalex

The OpenAlex for Biomarkers in Disease Mechanisms is on the source record.

What are the most-cited papers on Biomarkers in Disease Mechanisms?

ScholarIQmost cited works
Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease
Daniela Veit Barreto, Fellype Carvalho Barreto, Sophie Liabeuf, M. Temmar, Horst‐Dieter Lemke, Christophe Tribouilloy, Gabriel Choukroun, Raymond Vanholder, Ziad A. Massy
Kidney International. 2009306 CitationsOPEN ACCESS
Anti-Inflammatory and Active Biological Properties of the Plant-Derived Bioactive Compounds Luteolin and Luteolin 7-Glucoside
Sabrina Caporali, Alessandro De Stefano, Cinzia Calabrese, Alfredo Giovannelli, Massimo Pieri, Isabella Savini, Manfredi Tesauro, Sergio Bernardini, Marilena Minieri, Alessandro Terrinoni
Nutrients. 2022233 CitationsOPEN ACCESS
Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer
Yujuan Zhou, Qianjin Liao, Yaqian Han, Jie Chen, Zhigang Liu, Hang Ling, Jing Zhang, Wenjuan Yang, Linda Oyang, Longzheng Xia, Li Wang, Heran Wang, Lei Xue, Hui Wang, Bingqiang Hu
Journal of Cancer. 2016101 CitationsOPEN ACCESS
The soluble pattern recognition receptor PTX3 links humoral innate and adaptive immune responses by helping marginal zone B cells
Alejo Chorny, Sandra Casas-Recasens, Jordi Sintes, Meimei Shan, Nadia Polentarutti, Ramón García‐Escudero, A. Walland, John R. Yeiser, Linda Cassis, Jorge Carrillo, Irene Puga, Cristina Cunha, Hélder Novais Bastos, Fernando Rodrigues, João F. Lacerda, António Morais, Rebeca Dieguez‐Gonzalez, Peter S. Heeger, Giovanni Salvatori, Agostinho Carvalho, Adolfo García‐Sastre, J. Magarian Blander, Alberto Mantovani, Cecília Garlanda, Andrea Cerutti
The Journal of Experimental Medicine. 201682 CitationsOPEN ACCESS
Early and Transient Release of Leukocyte Pentraxin 3 during Acute Myocardial Infarction
Norma Maugeri, Patrizia Rovere‐Querini, Massimo Slavich, Giovanni Coppi, Andrea Doni, Barbara Bottazzi, Cecília Garlanda, Domenico Cianflone, Attilio Maseri, Alberto Mantovani, Angelo A. Manfredi
The Journal of Immunology. 201181 CitationsOPEN ACCESS

Where is Biomarkers in Disease Mechanisms research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Biomarkers in Disease Mechanisms is open access?

ScholarIQopen access share
80%OPEN ACCESS
Gold
30%
Green
0%
Hybrid
10%
Bronze
40%
Closed
20%

Related on ScholarIQ

470M+ articles · 14-day free trial